Inozyme Pharma shares owned by Citadel Advisors
Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Inozyme Pharma
Tip: Access up to 7 years of quarterly data
All positions including Inozyme Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inozyme Pharma by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $745k | 175k | 4.26 |
| 2023-09-30 | $712k | 170k | 4.20 |
| 2023-06-30 | $945k | 170k | 5.57 |
| 2023-03-31 | $4.7M | 823k | 5.73 |
| 2022-06-30 | $577k | 121k | 4.77 |
| 2022-03-31 | $402k | 98k | 4.09 |
| 2021-12-31 | $729k | 107k | 6.82 |
| 2021-09-30 | $1.1M | 95k | 11.59 |
| 2021-06-30 | $2.9M | 171k | 17.03 |
| 2021-03-31 | $4.7M | 240k | 19.68 |
| 2020-12-31 | $5.2M | 253k | 20.64 |
| 2020-09-30 | $6.3M | 241k | 26.29 |